1. Editors’ announcement

   • Peter H. Wiernik

   Announcement Pages: 1 - 1

2. Apoptosis and cell growth inhibition as antitumor effector functions of interferons

   • O. Sangfelt
   • H. Strander

   Review Article Pages: 3 - 14

3. Prognostic significance of Ki-67 nuclear proliferative antigen, bcl-2 protein, and p53 expression in follicular and diffuse large B-cell lymphoma

   • Marta Llanos
   • Hugo Alvarez-Argüelles
   • Norberto Batista

   Original Article Pages: 15 - 22

4. Epirubicin, cisplatin, and prolonged or brief infusional 5-fluorouracil in the treatment of carcinoma of unknown primary site

   • C. S. Karapetis
   • D. Yip
   • P. G. Harper

   Original Article Pages: 23 - 32

5. Interference of cytokeratin-20 and mammaglobin-reverse-transcriptase polymerase chain assays designed for the detection of disseminated cancer cells

   • William H. Krüger
   • Roman Jung
   • Axel R. Zander

   Original Article Pages: 33 - 38

6. The implication of compromised renal function at presentation in myeloma

   • B. Sirohi
   • R. Powles
   • P. Parikh

   Original Article Pages: 39 - 50

7. Serum levels of IL-1 beta, sIL-2R, IL-6, IL-8, and TNF-alpha in febrile children with cancer and neutropenia

   • Murat Soker
   • Leyla Çolpan
   • Kenan Haspolat

   Original Article Pages: 51 - 57

8. Biodistribution, blood half-life, and receptor binding of a somatostatin-dextran conjugate

   • Martin Behe
   • Jin Du
   • Anders R. Holmberg

   Original Article Pages: 59 - 64

9. Health-related quality of life in multiple myeloma patients receiving high-dose chemotherapy with autologous blood stem-cell support

   • N. Gulbrandsen
   • F. Wisløff
   • The Nordic Myeloma Study Group

   Original Article Pages: 65 - 77

10. Phase II trial of clarithromycin and pamidronate therapy in myeloma

    • T. C. M. Morris
    • L. Ranaghan
    • the Northern Ireland Regional Haematology Group

    Original article Pages: 79 - 84

11. Health-related quality of life and its potential prognostic implications in patients with aggressive lymphoma

    • M. Jerkeman
    • S. Kaasa
    • E. Cavallin-Ståhl

    Original Article Pages: 85 - 94

12. Vinorelbine-associated myelopathy in a patient who previously received paclitaxel

    • Ji-Youn Han
    • Byung Gil Choi
    • Kyung Shik Lee

    Case Report Pages: 95 - 97